• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Studies on Treatment Effects and Prognoses of Adoptive Immunotherapy of Cancer Patients by using autologous and allogeneic lymphocytes.

Research Project

Project/Area Number 06671888
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field 病態科学系歯学(含放射線系歯学)
Research InstitutionKanagawa Dental College (1995)
佐賀医科大学 (1994)

Principal Investigator

KUBOTA Eiro  Kanagawa Dental College, Professor, 歯学部, 教授 (50170030)

Co-Investigator(Kenkyū-buntansha) KATANO Mitsuo  Saga Medical School, Assistant Professor, 医学部, 講師 (10145203)
KITAKOGA Osamu  Saga Medical School, Resident, 医学部, 助手 (70264166)
KUROKAWA Hiroyuki  Saga Medical School, Resident, 医学部, 助手 (70225283)
GOTO Masaaki  Saga Medical School, Associate professor, 医学部, 助教授 (10145211)
KATSUKI Takeshi  Saga Medical School, Professor, 医学部, 教授 (70038868)
Project Period (FY) 1994 – 1995
Project Status Completed (Fiscal Year 1995)
Budget Amount *help
¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 1995: ¥400,000 (Direct Cost: ¥400,000)
Fiscal Year 1994: ¥1,500,000 (Direct Cost: ¥1,500,000)
Keywordshead and neck cancer / adoptive immunotherapy / allogeneic spleen cells / killer cells / anti-tumor cytokines / RT-PCR technique / 頭頸部癌
Research Abstract

Culture of peripheral blood mononuclear cells (PBMC) with a heat and penicillin-treated streptococcal preparation, OK-432, has induced effector cells which have both cell-mediated and cytokine-mediated antitumor activities. We performed locoregional adoptive immunotherapy (AIT) with OK-432-activated PBMC (OKMC) in head and neck cancer patients as a part of preoperative treatment. In the present study we evaluated the correlation of tumor mononuclear cell infiltration and patient's prognosis. The AIT group (10 cases) was more abundant in infiltrating T cells (UCHL-1+) in tumor tissue than those of the non-AIT group (10 cases). There were three recurrences out of 10 cases of AIT group, in which a small number of OKMC was transferred and had much less T cell infiltration of the tumor parenchyma.
Tumor tissues were surgically excised and therapeutic effect was examined histologically. In AIT group, focal necrosis of cancer tissue was observed at the site of OKMC injection especially at the portion of massive infiltration of mononuclear cells. These cell death was characteristic of apoptosis as examined by HE and immunohistochemical staining with anti-Le^y antibody. Various kind of cytokine mRNAs including IL-1, TNFalpha, IL-6, IFNgamma, IL-2, IL-4 were also detected in the tumor burden by RT-PCR technique. The IL-1 and IL-2 mRNA were detected in almost all of the tumor tissue, but IFNgamma was found only in 50% of these cases. Furthermore, tumor tissue which lack the IFNgamma message was unequivocally expressed immunosuppressive cytokine IL-10. The IFNgammamRNA was reappeared after the AIT in the tumor tissue which could not be detected its message before AIT.The above mentioned phenomena were presumed to be direct effect of AIT.Thus, it is considered that local administration of OKMC could be one of the most feasible BRM therapies in head and neck cancers.

Report

(3 results)
  • 1995 Annual Research Report   Final Research Report Summary
  • 1994 Annual Research Report
  • Research Products

    (23 results)

All Other

All Publications (23 results)

  • [Publications] Kubota E.: "Granulomatous hepatitis as a late complication of BCG immunotherapy for a stage III malignant melanoma patient-report of a case-" J Jpn Soc Cancer Ther. 30. 791-798 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Katano M.: "Inhibition of tumor cell growth by a human B-cell line" Biotherapy. 8. 1-6 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Koarada S.: "Efficient isolation of mutant antigen presenting cell lines by functional selection using T cell clones" J Immunol Meth. 182. 209-218 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Katano M.: "Interleukin-2 (IL-2) production by human B-cell line" Cell Immunol. 159. 262-270 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] 中村 光成: "多サイトカイン産生殺細胞性単核球移入(MCCM)療法の臨床効果" BIOTHERAPY. 9. 636-638 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Hu, ZL,Kubota E,Imamura H,Katano M,and Katsuki T: "Effective induction of human NK cells with OK-432 and further augmentation of their cytolytic function by rIL-2." Microbiol Immunol. 38. 183-190 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Katano M,Matsuo T,Morisaki T,Naito K,Nagumo F,Kubota E,Nakamura M,Hisatsugu T,and Tadano J: "Increased proliferation of a human breast carcinoma cell line by recombinant interleukin-2." Cancer Immunol Immunother. 39. 161-166 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Katano M,Morisaki T,Matsuo T,Nakamura M,Kubota E,and Hisatsugu H: "(1994) Interleukin-2 (IL-2) production by human B-cell line" Cell Immunol. 159. 262-270 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Kubota E,Katano M,Katsuki T,Enoki M,Mizuta T,Goto M,and Sakai T: "Granulomatous hepatitis as a late complication of BCG immunotherapy for a stage III malignant melanoma patient -report of a case-" J Jpn Soc Cancer Ther. 30. 791-798 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Katano M,Kubota E,Nagumo F,Matsuo T,Hisatsugu T,and Tadano J: "Inhibition of tumor cell growth by a human B-cell line" Biotherapy. 8. 1-6 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Katano M,Matsuo T,Morisaki T,Naito K,Nagumo F,Kubota E,Nakamura M,Hisatsugu T,and Tadano J: "Increased proliferation of a human breast carcinoma cell line by recombinant interleukin-2" Cancer Immunol Immunother. 39. 161-166 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Koarada S,Kubota E,Tokushima M,Naito K,Miyake K,and Kimoto M: "Efficient isolation of mutant antigen presenting cell lines by functional selection using T cell clones" J Immunol Meth. 182. 209-218 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Kubota E: "Granulomatous hepatitis as a late complication of BCG immunotherapy for a stage III malignant melanoma patient-report of a case-" J Jpn Soc Cancer Ther. 30. 791-798 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] Katano M: "Inhibition of fumor cell growth by a human B-cell line" Biotherapy. 8. 1-6 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] Koarada S: "Efficient isolation of mutant antigen presenting cell lines by functional selection using T cell clones" J Immunol Meth. 182. 209-218 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] Katano M: "Interleukin-2(IL-2) production by human B-cell line" Cell Immunol. 159. 262-270 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] 中村 光成: "多サイトカイン産生殺細胞性単核球移入(MCCM)療法の臨床効果" BIOTHERAPY. 9. 636-638 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] Kubota E: "Granulomatous hepatitis as a late complication of BCG immunotherapy for a stage III malignant melanoma patient-report of a case" J Jpn Soc Cancer Ther. in press (1995)

    • Related Report
      1994 Annual Research Report
  • [Publications] Hu ZL: "Effective induction of human NK cells with OK-432 and further augmentation of their cytolytic function by rIL-2" Microbiol Immunol. 38. 183-190 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] Katano M: "Increased proliferation of a human breast carcinoma cell line by recombinant interleukin-2" Cancer Immunol Immunother. 39. 161-166 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] 久保田英朗: "長期間培養したOK-432活性化ヒト末梢血単核球中に見いだされるNK活性を示す細胞のPhenotype解析" BIOTHERAPY. 8. 426-427 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] 久保田英朗: "OK-432によりヒト末梢血単核球中に誘導されるNK活性のサイトカインによる増強効果についての検討" BIOTHERAPY. 8. 692-694 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] 今村英夫: "局所養子免疫療法を行った頭頸部扁平上皮癌患者の治療効果と腫瘍内単核球浸潤との関係" BIOTHERAPY. 8. 604-606 (1994)

    • Related Report
      1994 Annual Research Report

URL: 

Published: 1994-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi